2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Recent advances in recurrent hepatocellular carcinoma therapy

YX Gao, QQ Ning, PX Yang, YY Guan… - World Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer,
accounting for 75%-85% of cases. Although treatments are given to cure early-stage HCC …

Surgical strategies for recurrent hepatocellular carcinoma after resection: a review of current evidence

F Milana, MA Polidoro, S Famularo, A Lleo, R Boldorini… - Cancers, 2023 - mdpi.com
Simple Summary Among primary liver cancers, hepatocellular carcinoma (HCC) is the most
common. Surgical resection and liver transplantation both represent potentially curative …

Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges

D Wang, M **ao, ZM Wan, X Lin, QY Li… - World Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Primary liver cancer is the sixth most commonly diagnosed cancer and was the third leading
cause of cancer deaths worldwide in 2020. It includes hepatocellular carcinoma …

The effect of a liver transplant program on the outcomes of resectable hepatocellular carcinoma: a nationwide multicenter analysis

M Serenari, J Lenzi, A Cucchetti, F Cipriani… - Annals of …, 2023 - journals.lww.com
Objective: To evaluate the effect of a liver transplantation (LT) program on the outcomes of
resectable hepatocellular carcinoma (HCC). Background: Surgical treatment of HCC …

Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis

J Liu, G Zhang, L Yang, D Yan, J Yu, S Wei, J Li… - European Journal of …, 2024 - Elsevier
Background Salvage liver transplantation (SLT) is an effective treatment option for recurrent
hepatocellular carcinoma (rHCC) following primary curative treatment (CUR). However, its …

Current role and perspectives of living donor liver transplantation for hepatocellular carcinoma: systematic review of the past 20 years

S Di Sandro, L Centonze, B Catellani, R Odorizzi… - Updates in Surgery, 2024 - Springer
Hepatocellular carcinoma (HCC) poses a significant global health challenge, and liver
transplantation (LT) remains the best curative option. Living donor liver transplantation …

[HTML][HTML] Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor …

T Toshima, J Rhu, YI Yoon, T Ito, H Uchida… - American Journal of …, 2024 - Elsevier
There are exceedingly uncommon but clearly defined situations where intraoperative
abortions are inevitable in living-donor liver transplantation (LDLT). This study aimed to …

Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation

J Chen, Y Fang, Z Tang, E Dong, J Gao, G Zhu… - Hepatology …, 2025 - Springer
Backgrounds and aims Hepatocellular carcinoma (HCC) is the most prevalent type of
primary liver cancer, characterized by a high rate of recurrence. This study aims to compare …

Precision surgery for hepatocellular carcinoma

CTJ Magyar, L Rajendran, Z Li, V Banz… - The Lancet …, 2025 - thelancet.com
Hepatocellular carcinoma arises in the setting of cirrhosis in most cases, requiring
multidisciplinary input to define resectability. In this regard, more precise surgical …